Kathryn DiMarco
Vermogen: 516 792 $ op 31-05-2026
Vermogen: 516 792 $ op 31-05-2026
Ms. Kathryn DiMarco is a Senior Vice President-Finance & Controller at Organon & Co. Ms. DiMarco was previously employed as a Controller by Allergan Ltd. (Ireland) and an International Controller by Merck Sharp & Dohme Corp.
She received her undergraduate degree from Lehigh University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ORGANON & CO. 0,01% | 31-03-2025 | 38.740 ( 0,01% ) | 516 792 $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ORGANON & CO. | Comptroller/Controller/Auditor | 01-05-2025 |
| ALLERGAN PLC | Comptroller/Controller/Auditor | 01-01-2020 |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Comptroller/Controller/Auditor | 01-01-2015 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Organon & Co.
Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau